#USA #Portland #Drug Discovery #Araceli Biosciences #Endeavor Live Cell

Araceli Biosciences Launches Endeavor® Live Cell

In a significant milestone for drug discovery, Araceli Biosciences has announced the launch of Endeavor® Live Cell, which aims to transform how researchers conduct kinetic imaging at an ultra-high throughput scale. This innovative platform enables scientists to capture real-time cellular dynamics, essential for advancing drug discovery processes that incorporate artificial intelligence (AI).

The Endeavor® Live Cell system allows for rapid kinetic imaging in 1,536-well plates, facilitating large-scale screening campaigns. As the pharmaceutical industry shifts toward more dynamic experimentation workflows, the ability to generate high-quality cellular imaging data quickly and consistently has become paramount. This necessity is particularly apparent in AI-driven drug discovery, which relies on extensive data sets for effective decision-making.

Matt Beaudet, CEO of Araceli Biosciences, elaborated on the purpose of this launch: “This release represents a major extension of the Araceli platform. Our goal is to streamline imaging not just for efficiency, but to assist scientists in generating high-quality biological data required for modern drug discovery efforts. With Endeavor® Live Cell, we are expanding our capabilities into dynamic biology, where speed, consistency, and automation compatibility are crucial.”

Key Features and Applications

The system is engineered for imaging intervals of around four minutes, allowing the exploration of live cellular phenomena and integrating them into high-throughput workflows. Its innovative design addresses the critical timing and uniformity required during experiments to close the loop between experimentation, analysis, and actionable insights.

Endeavor® Live Cell is ideal for various applications, including:

• - Response to Compounds: Tracking how cells behave in response to different drug candidates.
• - Monitoring Cell Health and Viability: Ensuring the cells remain healthy during experimentation.
• - Phenotypic Screening: Assessing phenotypic changes at a cellular level across multiple conditions.
• - Organoid and Spheroid Growth Tracking: Observing the development of complex tissue models in real-time.
• - Other Kinetic Assays: Benefiting from frequent measurements over a broad range of conditions.

This technology was developed in collaboration with Okolab, a company renowned for its expertise in maintaining stringent environmental controls for live-cell microscopy. Lara Petrak, Sales Director of Okolab USA, expressed excitement about the collaboration, stating, “By combining reliable environmental control for live cells with Araceli’s rapid, scalable, and automation-ready platform, scientists now have a powerful new means of studying dynamic biology in large-scale screening campaigns.”

Conclusion

Through the launch of Endeavor® Live Cell, Araceli Biosciences continues to bolster its role as a key infrastructure provider for imaging solutions that facilitate AI-driven drug discovery. The system aims to empower researchers by providing them with the essential cellular data needed for experimentation within controlled lab environments, known as Lab-in-the-Loop.

As researchers explore the nuances of cellular behavior, the introduction of Endeavor® Live Cell underscores the ongoing commitment to innovation in the pharmacological landscape. For more details on the product, visit www.aracelibio.com.

About Araceli Biosciences

Araceli Biosciences is at the forefront of developing high-performance cellular imaging platforms designed to assist researchers in generating scalable and reproducible biological data for drug discovery and advanced screening applications.

About Okolab

Okolab specializes in designing and manufacturing environmental control solutions for microscopy and other demanding applications, ensuring researchers can maintain stable and accurate conditions during live cell experiments.